TRICARE Pharmacy Program RFI (Draft Section C & H)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA) is conducting acquisition planning for the next generation TRICARE Pharmacy Program (TPharm6) contract. This is a Special Notice (RFI) seeking industry feedback on draft Section C (Statement of Work) and Section H (Special Contract Requirements). The program aims to provide comprehensive pharmacy services for approximately 9.5 million beneficiaries. Feedback and requests for one-on-one meetings are due by May 22, 2026, 12:00 PM Mountain Time.
Purpose & Scope
The objective is to administer the TRICARE Pharmacy Benefits Program, ensuring high-quality, cost-effective pharmacy services. The scope includes:
- Processing claims from various sources (retail, Mail Order Pharmacy (TMOP), Military Treatment Facilities (MTF), VA, Indian Health Services, State Medicaid Agencies).
- Administering a retail pharmacy network across the 50 states, DC, and U.S. territories.
- Operating the TRICARE Mail Order Pharmacy (TMOP) program.
- Performing claims adjudication, including eligibility, cost-sharing, Other Health Insurance (OHI) identification, and Drug Utilization Review (DUR).
- Managing clinical reviews, beneficiary and pharmacy support services, and ensuring system security and reliability.
- Supporting interfaces with government systems (e.g., DEERS, PDW, OMDS, Federal EHR).
Key Draft Documents
- Section C (Statement of Work): Details the program's objective, comprehensive scope of work, and numerous performance standards. These include 99.5% system availability, timely processing of reimbursement claims (95% within 10 days), and specific mail order prescription shipping times. It also outlines special requirements such as compliance with TRICARE policy, DoD Uniform Formulary, HIPAA, and the development of Quality Management and Continuity of Operations Plans.
- Section H (Special Contract Requirements): Outlines critical contractual terms including Organizational Conflicts of Interest (OCI) disclosure, cost control incentives based on drug pricing and dispensing fees, and extensive performance guarantees. These guarantees cover areas like Mail Order Pharmacy processing, system availability, clinical review, telephone service, and claims compliance/accuracy reviews, with associated financial penalties for non-compliance.
Submission & Meetings
- Comments and Questions: Must be submitted no later than May 22, 2026, 12:00 PM MT to dha.buckley.AD-SPT-CAE.mbx.tpharm6@health.mil. Include "Your Company Name and Draft Documents Response" in the subject line. A feedback document (TPharm6 feedback document.xlsx) is provided for structured input.
- One-on-One Meetings: Requests must be submitted by May 22, 2026, 12:00 PM MT via the link: https://forms.osi.apps.mil/r/zBn9EyRm0g. Meetings will be facilitated in summer 2026.
Contract Details
- Opportunity Type: Special Notice (RFI)
- Product Service Code: Q201 (Medical Managed Healthcare)
- Set-Aside: None specified.
- Agency: Defense Health Agency (DHA)
- Contacts: Viktoria Reed (viktoriya.s.reed.civ@health.mil, 3036763648) and Brooke Wolfe (brooke.a.wolfe.civ@health.mil, 3036763799).